Literature DB >> 22959119

Evidence for global reduction in brain cyclic adenosine monophosphate signaling in depression.

James M O'Donnell1, Ying Xu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22959119     DOI： 10.1016/j.biopsych.2012.07.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  8 in total

1.  Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior.

Authors:  Rolf T Hansen; Marco Conti; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

Review 2.  Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive decline.

Authors:  Rolf T Hansen; Han-Ting Zhang
Journal:  Brain Res       Date:  2013-04-25       Impact factor: 3.252

3.  Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior.

Authors:  Alan Umfress; Sarbjit Singh; Kevin J Ryan; Ayanabha Chakraborti; Florian Plattner; Yogesh Sonawane; Jayapal Reddy Mallareddy; Edward P Acosta; Amarnath Natarajan; James A Bibb
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

4.  Lateral diffusion of Gαs in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains.

Authors:  Andrew H Czysz; Jeffrey M Schappi; Mark M Rasenick
Journal:  Neuropsychopharmacology       Date:  2014-09-24       Impact factor: 7.853

5.  The role of ventral striatal cAMP signaling in stress-induced behaviors.

Authors:  Florian Plattner; Kanehiro Hayashi; Adan Hernández; David R Benavides; Tara C Tassin; Chunfeng Tan; Jonathan Day; Maggy W Fina; Eunice Y Yuen; Zhen Yan; Matthew S Goldberg; Angus C Nairn; Paul Greengard; Eric J Nestler; Ronald Taussig; Akinori Nishi; Miles D Houslay; James A Bibb
Journal:  Nat Neurosci       Date:  2015-07-20       Impact factor: 24.884

6.  Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System.

Authors:  Chong Zhang; Ying Xu; Han-Ting Zhang; Mark E Gurney; James M O'Donnell
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

Review 7.  Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.

Authors:  Eric P Knott; Mazen Assi; Sudheendra N R Rao; Mousumi Ghosh; Damien D Pearse
Journal:  Int J Mol Sci       Date:  2017-03-24       Impact factor: 5.923

8.  Description of a Novel Phosphodiesterase (PDE)-3 Inhibitor Protecting Mice From Ischemic Stroke Independent From Platelet Function.

Authors:  Michael Bieber; Michael K Schuhmann; Julia Volz; Gangasani Jagadeesh Kumar; Jayathirtha Rao Vaidya; Bernhard Nieswandt; Mirko Pham; Guido Stoll; Christoph Kleinschnitz; Peter Kraft
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.